Europe Protein Expression Market Report and Forecast 2024-2032

Europe Protein Expression Market Report and Forecast 2024-2032

Europe Protein Expression Market Report and Forecast 2024-2032 

Europe Protein Expression Market Outlook 

The global protein expression market size was valued at USD 3 billion in 2023, with Europe holding a significant market share. The market is driven by the increased protein-based research and development activities across the region. It is expected to grow at a CAGR of 6.70% during the forecast period of 2024-2032, with the values likely to attain USD 4.9 billion by 2032.

Key Takeaways

• The market is poised toward an upwards trajectory due to increased investment activities in the region. The German government invested EUR 38 million (nearly USD 41 million) in the protein transition in the 2024 federal budget.
• The Europe protein expression market share is likely to be driven by increasing partnership activities between market players. The market players strategically collaborating to increase the production of spider silk proteins, are predicted to play a pivotal role in the biomedical, cosmetics, and textiles industries.
• The opening of a new state-of-the-art protein production facility by BioAscent is anticipated to significantly fuel the market growth, indicating the prevalence of infrastructure improvements and investments.

Europe Protein Expression Market Analysis

The market is poised to be driven by the heavy government investments in the protein transition to support and promote alternative proteins. The investment is focused on human nutrition, expanding public research for plant-based foods and cultivated meat, and establishing the Proteins-of-the-Future Centre. In November 2023, the Budget Committee of the German Bundestag announced an EUR 38 million (nearly USD 41 million) investment for protein transition in the federal budget 2024. This strategic move may significantly impact the Europe healthcare domain. The technologies used in the production of alternative proteins can also be used to produce pharmaceutical proteins, contributing to the Europe protein expression market growth.

The market is witnessing significant moves by market players influencing the market. For example, In February 2024, BioAscent, a leading provider of integrated drug discovery services opened its state-of-the-art protein production facility. This move showcased the latest investment made by the company enhancing its in-house drug discovery capabilities with the ability to deliver protein production. The facility is announced to be run by well-experienced industry experts ensuring quality outcomes and propelling market growth. The investment in advanced technologies in the facility such as FPLC (fast protein liquid chromatography), high-pressure homogeniser, shaking incubators, along with a sonicator, and a Category II tissue culture lab, representing the involvement of technologically advanced equipment in the facility.

The Europe protein expression market share is projected to be driven by the rising demand for personalized therapeutics and the rapidly growing research and development activities that support protein expression. Additionally, the market is driven by strategic partnerships between market players to upscale the production and application of innovative materials in the healthcare sector. One such example is the strategic collaboration of AMSilk GmbH (Neuried, Germany), advanced materials specialist, and 21st.BIO (Copenhagen) biotech production specialist. The announcement was made in January 2024 about the companies coming together to accelerate the production of AMSilk’s E. coli-based recombinant spider silk protein. With the potential application of AMSilk's spider silk-based protein in biomedicals, this collaboration is poised to accelerate its production, potentially increasing its application in healthcare such as wound healing, and drug delivery systems among others. AMSilk's spider silk proteins, derived from plants, reduce CO2 emissions by 90%, use less land and water, and are animal-free, benefiting textiles, homecare, and biomedical industries.

Europe Protein Expression Market Segmentation  

Market Breakup by Product

• Expression Vectors
• Competent Cells
• Reagents
• Instruments
• Services

Market Breakup by Application

• Industrial
• Research
• Therapeutics

Market Breakup by System Type

• Mammalian Cell Expression System
• Yeast Cell Expression System
• Insect Cell Expression System

Market Breakup by End User

• Academic Research
• Contract Research Organizations
• Pharmaceutical and Biotechnology Companies

Market Breakup by Country

• United Kingdom
• Germany
• France
• Italy
• Others

Europe Protein Expression Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows: 

• Merck KGaA
• Sartorius AG
• Lonza Group AG
• Oxford Expression Technologies Ltd.
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Danaher Corporation
• Promega Corporation
• QIAGEN
• GenScript Biotech Corporation

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report. 

FAQs

• What was the Europe protein expression market value in 2023?  

The Europe protein expression market is expected to be driven by the robust research and development activities in the global protein expression market, which is anticipated to grow at a CAGR of 5.40% during the forecast period of 2024-2032 and is likely to reach a market value of USD 4.9 billion by 2032.  

• What are the major factors aiding the Europe protein expression market demand?  

The market demand is driven by the increasing preference for personalized medicines and growth in healthcare expenditure.

• What are the major Europe protein expression market trends? 

One of the significant trends in the market is the increasing investment activities by governments. Such as German government funding nearly 41 million USD in protein transition.

• What are the various products in the market?

Products in the market include expression vectors, competent cells, reagents, instruments, and services.

• Where does protein expression find application in the market?

They find wide applications in industrial, research, and therapeutic domains.

• What are the different types of protein expression systems in the market?

Various types of protein expression systems are mammalian cell expression systems, yeast cell expression systems, and insect cell expression systems.

• Who are the end users in the market?

End users in the market include academic research, contract research organizations, pharmaceutical and biotechnology companies.

• What is the market segmentation by countries? 

The market segmentation by countries includes the United Kingdom, Germany, France, and Italy.

• Who are the key players involved in the Europe protein expression market?

The key players in the market are Merck KGaA, Sartorius AG, Lonza Group AG, Oxford Expression Technologies Ltd., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Danaher Corporation, Promega Corporation, QIAGEN, and GenScript Biotech Corporation.

Meta description

Europe protein expression market is poised for growth, driven by the expansion of the global market, which was valued at USD 3 billion in 2023, and is projected to grow at a CAGR of 5.40% during the forecast period of 2024-2032.

*Please Note:* The report will take 7 business days to complete, after order confirmation.